Owner Allergan, Inc.

Inventors Devries, Gerald W.; Malone, Thomas; Edelman, Jeffrey; Whitcup, Scott M.; Hughes, Patrick M.; Spada, Lon T.; Baciu, Peter; Blanda, Wendy M.

Agent Davies Collison Cave

Pub. Number AU-B-2005244202

PCT Pub. Number WO2005/110436

Priority 60/567,423 30.04.04 US

Filing date 20 April 2005

Wipo publication date 24 November 2005

Acceptance publication date 4 November 2010

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61F 2/00 (2006.01) Filters

A61F 13/00 (2006.01) Bandages, dressings or absorbent pads

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 27/02 (2006.01) Drugs for disorders of the senses